Treatment of behçet’s disease - an update

Seminars in Arthritis and Rheumatism

Volumn 30, Issue 5, 2001, Pages 299-312

  Kaklamani, Virginia G ^a,b   Kaklamanis, Phaedon G ^a,b  

^a NEWTON WELLESLEY HOSPITAL   (United States)

^b ATHENS MEDICAL CENTER   (Greece)

Author keywords

Beh et's disease; Clinical trials; Treatment

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; COLCHICINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GLUCOCORTICOID; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PREDNISOLONE; RECOMBINANT ALPHA INTERFERON; SALAZOSULFAPYRIDINE; THALIDOMIDE;

ARTHRITIS; ARTICLE; BEHCET DISEASE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MENINGOENCEPHALITIS; META ANALYSIS; PRIORITY JOURNAL; RECURRENT DISEASE; STEROID THERAPY; UVEITIS;

EID: 0035052792     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1053/sarh.2001.19819     Document Type: Article

References (150)

1. Behçet's disease
2. Recent epidemiological features of Behçet's disease in Japan
3. Risk factors for vital organ involvement in Behçet's disease
4. Epidemiological features of Adamantiades-Behçet's disease in Germany and in Europe
5. Behçet's disease - Analysis of 3443 cases
6. Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behçet's syndrome
7. Behçet's syndrome
8. Behçet's disease and complex aphthosis
9. Criteria for diagnosis of Behçet's disease
10. APLAR validation of Behçet's disease diagnosis criteria: The Iran experience
11. Is there a place for large vessel disease in the diagnostic criteria of Behçet's disease?
12. Behçet's disease
13. Medical management of Behçet's syndrome
14. Management of the patient with Behçet's disease
15. Treatment of Behçet's disease
16. Corticosteroids and azathioprine: Their use in Behçet's syndrome
17. Joint manifestations in Behçet's disease. A review of 340 cases
18. Corticosteroid pulse therapy in neuro-Behçet's disease
19. Behçet's disease: An update
20. Neurological involvement in Behçet's syndrome: A prospective study
21. Practical treatment recommendations for pharmacotherapy of Behçet's syndrome
22. Pulmonary arterial aneurysms in Behçet's syndrome: A report of 24 cases
23. Seven-year follow-up of neurologic involvement in Behçet's syndrome
24. Multiple large aneurysms of pulmonary arteries in Behçet's disease. Clinical remission and radiologic resolution after corticosteroid therapy
25. Immunotherapy for Behçet's disease
26. Efficacy of oxaprozin in the treatment of articular symptoms of Behçet's disease
27. Treatment of Behçet's disease with indomethacin
28. Inefficacy of azapropazone in the acute arthritis of Behçet's syndrome: A randomized double blind placebo controlled study
29. The arthritis of Behçet's disease: A prospective study
30. Leucocyte movement and colchicine treatment in Behçet's disease
31. Colchicine in the treatment of cutaneous manifestations of Behçet's disease
32. Colchicine in Behçet's disease
33. A double blind study of colchicine in Behçet's disease
34. Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease
35. Long-term effects of cyclophosphamide and colchicine treatment in Behçet's disease
36. Combined ciclosporin and colchicine therapy for uveitis in Behçet's disease
37. A double blind study of colchicine in Behçet's syndrome (BS)
38. Cyclosporin in Behcet's disease
39. Cyclosporin in Behçet's disease
40. Effectiveness of cyclosporine therapy for Behçet's disease
41. Cyclosporine A is effective but not safe in the management of Behçet's disease
42. Cyclosporin A in the treatment of severe Behçet's uveitis
43. Short term cyclosporin A treatment of Behçet's disease
44. Cyclosporine in Behçet's disease resistant to conventional therapy
45. La macula dans le syndrome d'Adamantiades-Behçet
46. Cyclosporin-A-therapie des Morbus Behçet
47. A retrospective study of therapeutic response and visual outcome in patients with eye disease
48. Long-term follow-up of cyclosporin-A-treated patients with Behçet's disease
49. Sandimmun treatment of uveitis in Behçet's disease
50. Cyclosporin in the management of Palestinian patients with Behçet's disease
51. Terapia con ciclosporina A dell'uveite endogena e delle manifestazioni oftalmologiche della malattia di Behçet
52. Cyclosporine therapy in Behçet's disease
53. Cyclosporin in Behçet's disease: Results in 16 patients after 24 months of therapy
54. Behçet's disease: Report of a case with refractory ocular manifestations and response to cyclosporine (Sandimmun) therapy
55. Low-dose cyclosporin in Behçet's disease: Follow-up controlled study with emphasis on extraocular manifestations and neuro-Behçet's disease
56. Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Behçet's disease
57. Evaluation of conventional therapy versus cyclosporine A in Behçet's syndrome
58. Effect of cyclosporine A on the hearing loss in Behçet's disease
59. Topical cyclosporine-A for treatment of oral ulcers of Behçet's syndrome
60. Low dose cyclosporin A versus pulsed cyclo-phosphamide in Behçet's syndrome: A single masked trial
61. Treatment of Behçet's disease with chlorambucil
62. Long-lasting remission of Behçet's disease after chlorambucil therapy
63. Chlorambucil in the treatment of uveitis and meningoencephalitis of Behçet's disease
64. Treatment of Behçet's disease with chlorambucil
65. Behçet's syndrome
66. Behçet's disease
67. A controlled trial of azathioprine in Behçet's syndrome
68. Azathioprine in Behçet's syndrome: Effects on long-term prognosis
69. The management of Behçet's syndrome: How are we doing?
70. Behçet's syndrome
71. Azathioprine for the treatment of ophthalmological lesions of Behçet's disease
72. Pulse cyclophosphamide in Behçet's disease
73. Pulse cyclophosphamide in ophthalmic manifestations of Behçet's disease
74. Efficacy of cyclophosphamide therapy in audiologic involvement of Behçet's syndrome
75. Combination therapy with low dose pulse cyclophosphamide and methotrexate in ocular lesions of Behçet's disease
76. CT findings of pulmonary artery aneurysms during treatment for Behçet's disease
77. Pulse cyclophosphamide (PCP) for ocular lesions of Behçet's disease: Double blind crossover study
78. Behçet's syndrome: How should we treat it?
79. Detection of RNA complementary to herpes-simplex virus in mononuclear cells from patients with Behçet's syndrome and recurrent oral ulcers
80. CD4 and CD8 cell responses to herpes simplex virus in Behçet's disease
81. Lack of association between chronic hepatitis C virus infections and Behçet's disease
82. Interferon-α treatment of Behçet's disease
83. Treatment of Adamantiades-Behçet's disease with systemic interferon alpha
84. Behçet's syndrome: Treatment with recombinant leukocyte alfa-interferon
85. Morbus Behçet und exogenes interferon: Erfolgreicher behandlungsversuch mit recombiniertem α-A-IFN
86. Therapeutischer einsatz von a-interferon bei metastasierendem melignem melanom disseminiertem Kaposi-sarkom und schwerem Morbus Behçet
87. Morbus Adamantiades-Behçet. Therapeutischer Einsatz von systemischem rekombinantem interferon-a-2a
88. Interferon therapy for Behçet's disease
89. Erosive arthritis and posterior uveitis in Behçet's disease. Treatment with interferon α and interferon γ
90. Possible association between Behçet's syndrome and chronic hepatitis C virus infection
91. Interferon alpha-2a in the treatment of Behçet's disease
92. Systemic interferon-alfa in the treatment of Adamantiades-Behçet's disease
93. L'alfa-interferone nella malattia di Behçet
94. Therapy of ocular Behçet's disease with recombinant human interferon-2α
95. Alfa interferon therapy in Behçet's disease related uveitis: Report of two cases
96. The long-term treatment with interferon alpha-2A in Behçet's disease
97. Loss of vision and diarrhoea
98. Beneficial effects of interferon-alpha 2b in Behçet's disease
99. Interferon alpha-2B for refractory ocular Behçet's disease
100. Systemic interferon a2b treatment in Behçet's syndrome
101. Interferon-alpha 2b for refractory ocular Behcet's disease
102. Alpha interferon in Behçet's disease
103. Utilizacion de interferon alfa 2r en el tratamiento de las uveitis autoimmunes (primarias a associadas a enfermedad de Behçet)
104. Interferon a for ocular Behçet's disease
105. Efficacy and safety of systemic recombinant interferon-alpha in Behçet's disease
106. Treatment of ocular Behçet's disease (BD) with recombinant human interferon-á2á (rhIFNá2á) - A three center pilot study
107. Inefficacy of topical alpha interferon in the treatment of oral ulcers of Behçet's syndrome: A randomized double blind trial
108. Behçet's disease in patients with chronic myelogenous leukemia: Possible role of interferon-alpha treatment in the occurrence of Behçet's symptoms
109. Low-dose weekly methotrexate for unusual neutrophilic vascular reactions: Cutaneous polyarteritis nodosa and Behçet's disease
110. Low dose weekly methotrexate therapy for progressive neuro-Behçet's syndrome: A follow up study for 36 months
111. Methotrexate for ocular lesions of Behçet's disease. Cohort study on 262 patients
112. Methotrexate in the treatment of ocular lesions of Behçet's disease in children
113. Clinical trial of sulfasalazine for treatment of uveitis in Behçet's disease
114. Clinical and immunohistological studies on intestinal Behçet's disease
115. Penicillin in treatment of Behçet's disease
116. Benzathine-penicillin in the prophylaxis and treatment of Behçet's disease
117. The effect of prophylactic penicillin treatment on the course of arthritis episodes in patients with Behçet's disease. A randomized clinical trial
118. Effect of prophylactic benzathine penicillin on mucocutaneous symptoms of Behçet's disease
119. Minocycline effects on the clinical symptoms in correlation with cytokines produced by peripheral blood mononuclear cells stimulated with streptococcal antigens in Behçet's disease
120. Treatment of severe colitis in Behçet's syndrome with thalidomide (CG-217)
121. Treatment of Behçet's disease with thalidomide
122. Thalidomide effects in Behçet's syndrome and pustular vasculitis
123. Thalidomide in the treatment of Behçet's syndrome
124. Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behçet's disease: Use of neurophysiological studies to detect thalidomide neuropathy
125. Low dose thalidomide treatment of Behçet's syndrome
126. Treatment of aphthae with thalidomide
127. Treatment de l'aphthoses par la thalidomide et la colchicine
128. Crossover study of thalidomide vs placebo in severe recurrent aphthous stomatitis
129. Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized double-blind placebo-controlled trial
130. Traitement de l'aphthose recurrence par thalidomide à faible dose. Etude pilote chez 17 patients
131. Behçet disease and the emergence of thalidomide
132. Suppression of Behçet's disease with dapsone
133. Treatment of Behçet's disease with dapsone
134. Successful treatment of Behçet's disease with pentoxifylline
135. Behçet's disease in children
136. Successful treatment of ischemic leg ulcer in a patient with occlusive vasculo-Behçet's syndrome with pentoxifillin
137. The therapeutic and immunological effects of levamisole in recurrent oral ulcers and Behçet's syndrome
138. Treatment of Behçet's syndrome with levamisole
139. Treatment of Behçet's disease with levamisole
140. Local intralesional therapy with rhGM-CSF for a large genital ulcer in Behçet's disease
141. 5% Amlexanox oral paste a new treatment for recurrent minor aphthous ulcers. I. Clinical demonstration of acceleration of healing and resolution of pain
142. The beneficial effect of rebamipide on recurrent oral aphthous ulcers in Behçet's disease
143. The use of sucralfate suspension in the treatment of oral and genital ulceration of Behçet's disease. A randomized placebo-controlled double-blind study
144. Use of proprietary agents to relieve recurrent aphthous stomatitis
145. The management of Behçet's syndrome
146. Vasculitis in Behçet's disease
147. Therapy of Behçet's disease
148. Treatment of severe uveitis of Behçet's syndrome with the combination of Interferon-á2B and azathioprine. An open study
149. The ten-year mortality in Behçet's syndrome
150. Treatment and visual prognosis in Behçet's disease